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Abstract: 
Resume. This publication provides an overview of domestic and foreign 
literaturefor the period from 2011 to 2020. Risk factors for the development of 
malignant neoplasms of the mammary glands were analyzed. The role of the 
following factors is considered: genetic, chronic inflammatory and hyperplastic 
diseases of the genitals, reproductive function, hormonal and metabolic 
disorders, frustrating situations, the presence of somatic pathology, ionizing 
radiation, and previous surgical trauma of the breast. The results of some cohort 
epidemiological studies of the influence of these factors (both individual and 
their combinations) on the development of breast cancer are presented. 
Keywords: ракbreastcancer, факторыrisk factors. Abstract. This review 
summarizes the factors of potential risk of breast cancer. Much attention was 
focused on genetic factor, chronic inflammatory and hyperplastic diseases of 
endometrium, reproductive function, hormonal and metabolic disorders, 
frustration, somatic pathology, ionizing radiation, before surgery. We discussed 
the results of some cohort and epidemiological studies of these risk factors 
(involvement either separate or the joint effect) in breast cancer development. 
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INTRODUCTION 
To date, the problem of breast cancer (BC) remains an extremely urgent problem around the 
world. In many economically developed countries, this is the most common form of cancer in 
women, accounting for 28.0% of all female malignancies in France, 29.0 % in the United 
States, 24.0 % in Sweden, and Japan— 13,9 % [13; 12; 14]. 
Science and innovation inIn the Russian Federation, this figure was expected to reach 17.9% 
in 2017. Over the past 10 years, standardized incidence rates of breast cancer (BC) in the 
Russian Federation have been established. Deaths in Russia increased by 42.0 %, and deaths 
— by 43.0 %. Therefore, improving early diagnosis of breast cancer in Russia over the last 
decade, noted: in 2017, the detection rate for stage I and II was 62.3 %, and the proportion of 
advanced forms (stage III and IV) — 36,8 %. The overall 5-year survival rate for this form of 
tumor in Russia, accounting for 56.3 %, mortality in the 1st year of life was 10.1% [14; 13]. 
In Russia, the main cause of death of women of reproductive age is breast cancer [2; 11]. 
High levels of breast cancer morbidity and mortality make us look for new methods of 
preventing this pathology, based on a deep knowledge of the etiological and pathogenetic risk 
factors. The appearance and development of breast cancer is associated with many factors. 
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These reasons include heredity, factors of reproductive history, hormonal, somatic and 
previous diseases of the mammary glands, anthropometric, other endogenous factors, as well 
as environmental influences (ionizing radiation, dietary patterns, exposure to chemical and 
physical carcinogenic agents, etc.) [1; 11;19; 18]. 
The GENETIC PREDISPOSITION FACTOR has recently become a global problem of 
etiology, pathogenesis, early diagnosis and prevention of breast cancer is associated with 
discoveries in the field of molecular genetics, which made it possible to identify genes 
involved in the process of carcinogenesis and determine predisposition to this disease. 
Hereditary changes that are inherited and highly likely to lead to cancer development are 
usually expressed in mutations of one allele гена-of the suppressor gene. To date , a number 
of suppressor genes have been identified, the congenital mutations of which lead to the 
development of hereditary and familial forms of malignant neoplasms (MN). Thus, the genes 
referred to as breast cancer genes HSCL 1, HSCL 2, inherited damage to which increases the 
risk of developing malignant breast tumors [19; 20]. Criteria for making a genetic diagnosis 
of hereditary breast cancer include the presence in the family of 2 or more relatives of the I - 
II degree of kinship suffering from breast cancer, the early age of the disease manifestation, 
bilateral mammary gland damage, the primary multiplicity of neoplasms in the proband or his 
relatives, specific tumor associations [1; 2; 6]. At the moment, at least 8 hereditary 
(monogenic) syndromes have been identified, which manifest themselves as familial pre-race. 
Science and innovation lead to the occurrence of breast cancer [18; 20]. Some of the above 
are organ-specific: familial ovarian cancer, familial endometrial cancer, and familial breast 
cancer. 5 syndromes are variants of familial cancer syndrome and are manifested by a 
systemic predisposition to the occurrence of ovarian, breast, endometrial and some other 
localizations. These include familial breast/ovarian cancer syndrome; familial breast/ 
ovarian/endometrial cancer syndrome; familial breast/ovarian/endometrial /colon cancer 
syndrome (Lynch2 syndrome); familial breast/endometrial/gastrointestinal/lung cancer 
syndrome; and familial endometrial/gastrointestinal cancer syndrome. Individuals who have 
inherited the breast cancer predisposition gene have a 100 % chance of developing these 
tumors by the age of 40-55. The general population risk of developing breast cancer, made up 
by 90 years of life of women, is 1.0-6.0 % [19]. It is assumed that 50.0 % of carriers of the 
abnormal VYASL1 gene develop breast cancer before the age of 50, and women with a 
personal history of breast cancer are at extremely high risk (up to 65.0 %) of developing 
primary contra lateral breast cancer [16]. The risk of developing ovarian cancer for such 
women is about 44.0% [16]. The latest literature data, which deserve special interest, were 
obtained in the study of R.Magleu e! a1. [20], who followed 3303 women for 17 years. There 
is information that the presence in the family of patients of relatives of the first degree of 
kinship suffering from breast cancer increases the risk of developing this disease by 2.5 times 
both in the presence of atypical hyperplasia and without it. A burdened family history slightly 
increases the risk of breast cancer in women without proliferative changes in breast tissue, 
but in the presence of calcifications together with a burdened family history, the risk 
increases, which is the reason for including such women in the risk group. In the same study, 
it was shown that the absolute risk of breast cancer associated with atypical hyperplasia was 
20.0 % within 15 years after the initial biopsy study [20]. &Magkoroi he pointed out the 
relationship of breast cancer with cystic changes in breast tissue. A small group of 
researchers concluded that the presence of cysts increases the risk of breast cancer in women 
who have relatives of the first degree of kinship, suffering from a similar disease. Such an 
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association was not observed among women without a family burden [11]. 
Science and innovation D. Coradini and M. Daidone [16] examined 25 DNA samples isolated 
from proliferatively altered breast tissues, includingпротоковыеintraductalpapillomas, for 
loss of heterozygosity and microsatellite instability at 10 loci, including locus D 17B 579 
(area of the VYASL 1 gene), and found an incomplete correlation between genetic changes 
and proliferation with atypia. An important outcome of this study was that genetic changes 
can occur in the absence of clear clinical signs preceding malignant ones, and in these cases it 
is necessary to rely on a burdened family history [16]. PREVIOUS BREAST DISEASES It 
has been noted that the contribution of benign tumors is also significant in the development 
of breast cancer [15]. &Magleugh [10] observed the fate of 1,950 patients diagnosed with 
fibroadenoma and a combination of fibroadenomatosis and fibrocystic disease. The control 
group consisted of the sisters of the husbands of these women. The dynamics of the risk of 
developing breast cancer at a single fibroadenomas was 2.17 and increased to 3.1 in patients 
in the presence of combined fibroadenomas and cysts, fibroadenomas, and sclerosing of 
adenose, the calcification or papillomatosis, with burdened family history of accumulated 25-
year risk of 20.0 %. 2/3 of patientswith single fibroadenoma and healthy relatives, risking to 
get sick BC along with women from the General population [11]. The risk of malignancy was 
determined by the degree of proliferation in fibroadenomatosis. Initial data showed that with 
atypical lobular hyperplasia, the risk of breast cancer increases 3-6 times, with 
intraductalгиперhyperplastic processes-2 times. With cystic changes, sclerosingadenosis, and 
othernon-hyperplastic changes, the risk of developing breast cancer did not significantly 
differ from среднепопуляционногоthe average population [10; 15]. REPRODUCTIVE 
FACTORS Among the etiological factors of breast cancer, a significant role belongs to 
gynecological diseases, primarily inflammatory processes in the uterine appendages [3; 14]. 
This is due to the fact that the mammary glands, as well as the uterus, are a target organ for 
sex hormones. A. S. Zotov notes that mastopathy is often found in hyperestrogenemia, the 
manifestations of which are: dysfunctional uterine bleeding, anovulatory infertility, uterine 
fibroids, endometriosis, ovarian follicular cysts [17]. Hormone imbalance contributes to the 
morphofunctional reorganization of the mammary glands, and in some women this process 
does not go beyond the physiological norm, while in others, under the conditions of 
activation of the mammary gland receptor apparatus, pathological changes are formed — 
mastopathy — cancer [8]. 
Pathological changes in the mammary glands are common in women with endometrioid 
heterotopias (76.0 %). With retrocervical endometriosis, they occur in 92.3 % of women, 
with endometrioid ovarian cysts-in 88.9 %, with adenomyosis - in 82.3 %. The frequency of 
nodular forms of mastopathy in such women ranges from 29.6 % to 38.5 % [12].Lapochkina 
demonstrated a direct correlation between mastopathy and gynecological diseases such as 
uterine fibroids, endometriosis, and endometrial hyperplasia [14]. Their prevalence in women 
with fibrocystic disease of the mammary glands exceeds 90,0 %. S. H. Ghanaiansudelat 
attention to the relationship of increased risk of breast cancer with late menopause and early 
menarche [9]. I. I. Frolova found that the occurrence of breast cancer is directly proportional 
to the time of occurrence of menarche and the first pregnancy and is inversely proportional to 
the number of children [19]. By phone, V. I. Starikova risk of breast cancer in menopause 
after 55 years is 2-2.5 times higher than in menopause before 45 years. On the other hand, the 
risk of breast cancer has been shown to decrease by 47.0 % in women with ovaries removed 
for various reasons under the age of 40 compared to the cohort of women with natural 
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menopause aged 45-54 years [17]. According to literature data, V. P. Kharchenko and N. I. 
Rozhkova, women who have the onset of menstruation before the age of 13, and the onset of 
menopause after 55 years, have a 2-2.5 times higher risk of developing breast cancer [10]. 
One of the most important risk factors contributing to breast cancer is the high frequency of 
cycles without ovulation and their hormonal manifestation — progesterone deficiency [14]. 
Abortion is considered an important risk factor. It not only damages the uterus, but also 
causes various disorders in the hypothalamic-pituitary-ovarian system, interrupts 
physiological proliferative processes in the mammary glands. According to many authors, it 
is emphasized that 3 or more abortions have a particularly unfavorable effect on the state of 
the breast [5; 2; 4]. According to some authors, the risk of breast cancer increases even more 
in the absence of childbirth and a large number of artificial and spontaneous abortions [6]. 
Women who give birth for the first time before the age of 18 are significantly less likely to 
develop breast cancer than women who give birth for the first time at the age of 35 and above 
[10].Sinschyn believe that women who have had a late first birth (at the age of more than 30 
years) The risk of developing breast cancer is 2 to 3 times higher than that of those who gave 
birth before the age of 20. Every subsequent birth before the age of 30 is accompanied by a 
further reduction in risk. The risk of developing breast cancer before the age of 40 is 5.3  
Science and innovation are twice as high in women who gave birth at the age of more than 30 
years than in those who gave birth before 20 years [8]. It is interesting that early delivery 
does not have a protective effect in women who have mutations of VJASL 1 or VJASL 2. 
Women who gave birth — carriers of mutations of VJASL 1 or VJASL 2 are significantly 
more likely (1.71 times) to develop breast cancer before the age of 40 than those who did not 
give birth. Each pregnancy is associated with an increased risk of developing breast cancer 
before the age of 40 [3]. S. T.Vgees has shown that preventive oophorectomy in carriers of 
the VYASL 1 or VYASL 2 mutations: a) reduces the risk of ovarian cancer by 96.0 %; b) 
reduces the risk of breast cancer by 53.0 % [7]. Numerous scientific studies that have been 
devoted to studying the effect of hormonal contraceptives and hormone replacement therapy 
on the risk of breast cancer give rather contradictory information [13]. The risk of further 
development of benign diseases and breast cancer increases in women who took 
contraceptives before the birth of their first child [12]. When using contraceptives and 
aborting the first pregnancy, the relative risk of developing breast cancer increases by 2.4 
times [17]. GB.Fentiman notes that women who have used hormonal contraceptives for more 
than 5 years have a 9-fold increased risk of developing breast cancer. The use of oral 
contraceptives (COCs) reduces the risk of ovarian cancer and endometrial cancer by 2-3 
times, without having a pronounced protective effect on breast tissue from malignant 
transformations [14]. Research by S. T. Brece [14] demonstrated that the incidence of breast 
cancer among women aged 60 years who used and did not use COCs is exactly the same. 
According to the latest data from the 3rd European Breast Cancer Conference (Barcelona, 
2012), there was no association between oral contraceptive use and the development of breast 
cancer. At the same time, no correlation was found between the use of COCs and age, race, 
body mass index, duration of use and age of initiation of COCs, and duration of use until the 
first completed pregnancy [19]. There is also evidence of increased cancer risk in women 
over 45 years of age who continue to use COCs [13]. According to some authors , prolonged 
lactation is a factor that reduces the risk of cancer [17; 15], while others report a negligible 
effect of this factor [12]. The short duration of the lactation period (up to 5 months) is one of 
the risk factors for breast cancer [18]. 
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Science and innovation SOMATIC DISEASES Some epidemiological studies have shown 
that patients suffering from breast cancer have a higher incidence of thyroid diseases than in 
the general population, from 9.0 % to 50.0% or more [12]. The thyroid gland has a great 
influence on the formation and functioning of a woman's reproductive system. Against this 
background, changes in the activity of the thyroid gland during critical periods of a woman's 
life: puberty, pregnancy, lactation, and menopause are indicated [6; 2]. If there is a pathology 
of the thyroid gland, it can cause premature or late puberty, amenorrhea, galactorrhea, and 
infertility [1,3]. There is clear evidence of a combination of changes in thyroid function with 
a sharp decrease in the level of yellow body hormones. There is a concept of the relationship 
between the function of the thyroid gland and the thyroid-stimulating function of the pituitary 
gland, as well as the influence of the latter on the luteinizing function of the pituitary gland. 
More than half (66.0%) of patients with various forms of mastopathy had thyroid pathology. 
Hypofunction of the thyroid gland increases the risk of breast cancer by 3.8 times [4; 5]. An 
important role is played by the presence of a metabolic syndrome. Insulin resistance and 
hyperinsulinemia as development factors of the metabolic syndrome are risk factors for the 
development диспластическихof breast dysplastic diseases due to an increase in the level of 
insulin-like growth factors [6; 5]. Obesity is also accompanied by insulin resistance and, as a 
result, hyperinsulinemia, which contributes to an increase in the level of insulin-like growth 
factors in the body. Also, excess fat is a source of extra-gonadal synthesis of sex steroids, in 
particular androgens, which ароматазыare converted to estrogens under the influence of the 
aromatase enzyme, which is accompanied by hyperestrogenism, the latter, in turn, stimulates 
proliferative processes in breast tissues [7,18]. дисгормональнойLiver diseases play a 
certain role in the formation of dyshormonal pathology of the mammary glands. Diseases of 
the hepatobiliary system most often initiate the development of chronic 
гиперэстроhyperestrogenism due to delayed utilization of estrogens in the liver. These data 
are confirmed by the high frequency of hyperplastic processes in the mammary glands in 
liver diseases [9; 13]. Among the risk factors mentioned are a tendency to fatness and the 
presence of arterial hypertension. Obesity may increase the risk of breast cancer in 
menopausal women and does not affect the risk in menstruating women [10; 19]. 
Science and innovation A number of authors have observed a link between high growth and 
breast cancer incidence [17]. FRUSTRATING FACTORS are calculated as an indicator of 
breast cancer risk at the social (environmental) and individual levels. There is a 1.5-fold 
increase in the risk of developing tumors in urban areas compared to rural areas [11]. As the 
quality of life of women improves, there is an increase in the incidence rate. In developed 
social strata, persons with higher education have a high incidence of breast cancer — RR = 
1.7 in relation to RR = 1.0 in unskilled workers. The importance of social environment 
factors for the development of tumors of this localization is noted [13]. Epidemiological 
studies of precancerous and tumorous diseases of the mammary glands have repeatedly noted 
the relationship between marital status and the occurrence of these diseases. Calculations 
performed by L. A.Pustyrskystudies show that the relative risk of breast cancer is 1.54 times 
higher in unmarried women and 1.2 times higher in divorced women [14]. According to 
anamnestic data, only 6.9% of the total number of patients have a conflict situation at work 
[15]. A more unfavorable analysis was obtained in the analysis of family relationships. Out 
как ,of the total number, 39.8% of patients reported conflict situations at home [16]. If 
continuous domestic conflicts lead to a gradual accumulation of neuropsychiatric disorders, 
then severe sudden shocks, as a rule, cause a rapid deterioration of the clinical picture. The 
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proportion of patients who had severe shocks in the period preceding the examination was 
14.7 % in the unmarried group and 6.3 % in the married group [11]. According to M. I. 
Davydov, emotional stress increases the risk of transition from a non-proliferative form of 
nodular mastopathy to a proliferative one by 3.3 times [10]. Today, much attention is paid to 
studying the influence of a woman's sexual function on the likelihood of mastopathy and 
breast cancer: among nuns, as well as among single women, the incidence of breast cancer is 
2 times higher than in married women. Psychosexual discomfort is a powerful stressful factor 
[15] 
Nutrition plays an important role in the etiology of ZN [16]. At least 1/3 of them are related 
to the nature of nutrition. Increased physical activity, both professional and sports-related, 
reduces the risk of cancer development [7,16, 14].  
Science and Innovation Recent research has shown that alcohol consumption increases the 
risk of breast cancer by 1.5-2 times [15]. INJURY FACTOR According to some authors, 
trauma in the anamnesis of breast cancer patients is 4.7 times more common compared to the 
control, the presence of trauma in the anamnesis of breast cancer patients was noted in 7.33 
% [11]. The authors also note the association of breast cancer with past mastitis. One of the 
observations indicated that in 5.7% of cases, the tumor was preceded by inflammatory 
processes in the mammary gland [13,15]. The influence of the factor of surgical intervention 
on the mammary gland is poorly studied. It is no secret that breast surgery for fibroadenoma 
increases the risk of breast cancer by 4 times [11].  
CONCLUSION 
At the present stage, no specific risk factor for breast cancer development has been identified, 
since the disease is multi-factorial, associated with both genetic prerequisites and 
environmental influence [17]. In addition, all these factors are often found in the group of 
healthy women who do not develop breast cancer during their lifetime. In 4.0 - 8.0% of cases, 
malignant neoplasms of the breast are diagnosed in the absence of any risk factor (breast 
pathology, dyshormonal disease, etc.) [1,13,14]. This trend requires a more in-depth detailed 
study of various risk factors, detection of the most unfavorable combinations of them, and 
search for new, previously unknown factors that affect the development of breast cancer or 
prevent it. 
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